Point-of-care molecular diagnosis of Mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction.

<h4>Objectives</h4>Macrolides are generally considered to be the drugs of choice for treatment of patients with Mycoplasma pneumoniae infection. However, macrolide-resistant M. pneumoniae has been emerging since about 2000. The Smart Gene® system (MIZUHO MEDY Co., Ltd., Tosu, Japan) is a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nobuhisa Ishiguro, Rikako Sato, Toshihiko Mori, Hiroshi Tanaka, Mitsuo Narita, Takashi Nagano, Masato Owaku, Kensuke Miyajima, Atsushi Manabe
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0d34ac3c3b04407ea84290c83899f472
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0d34ac3c3b04407ea84290c83899f472
record_format dspace
spelling oai:doaj.org-article:0d34ac3c3b04407ea84290c83899f4722021-12-02T20:16:53ZPoint-of-care molecular diagnosis of Mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction.1932-620310.1371/journal.pone.0258694https://doaj.org/article/0d34ac3c3b04407ea84290c83899f4722021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0258694https://doaj.org/toc/1932-6203<h4>Objectives</h4>Macrolides are generally considered to be the drugs of choice for treatment of patients with Mycoplasma pneumoniae infection. However, macrolide-resistant M. pneumoniae has been emerging since about 2000. The Smart Gene® system (MIZUHO MEDY Co., Ltd., Tosu, Japan) is a novel fully automated system for detection of pathogens using the method of quantitative polymerase chain reaction (qPCR) with QProbe (QProbe PCR). The entire procedure is completed within 50 min and the size of the instrument is small (15 x 34 x 30 cm). The purpose of this study was to evaluate the usefulness of the Smart Gene® system for detection of M. pneumoniae and detection of a point mutation at domain V of the 23S rRNA gene of M. pneumoniae.<h4>Materials</h4>Pharyngeal swab samples were collected from 154 patients who were suspected of having respiratory tract infections associated with M. pneumoniae.<h4>Results</h4>Compared with the results of qPCR, the sensitivity and specificity of the Smart Gene® system were 98.7% (78/79) and 100.0% (75/75), respectively. A point mutation at domain V of the 23S rRNA gene was detected from 7 (9.0%) of 78 M. pneumoniae-positive samples by the Smart Gene® system and these results were confirmed by direct sequencing. The minimum inhibitory concentrations of clarithromycin among the 5 isolates of M. pneumoniae with a point mutation at domain V of the 23S rRNA gene were >64 μg/ml and those among the 33 isolates without a mutation in the 23S rRNA gene were <0.0625 μg/ml.<h4>Conclusion</h4>The Smart Gene® system is a rapid and accurate assay for detection of the existence of M. pneumoniae and a point mutation at domain V of the 23S rRNA gene of M. pneumoniae at the same time. The Smart Gene® system is suitable for point-of-care testing in both hospital and outpatient settings.Nobuhisa IshiguroRikako SatoToshihiko MoriHiroshi TanakaMitsuo NaritaTakashi NaganoMasato OwakuKensuke MiyajimaAtsushi ManabePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 10, p e0258694 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Nobuhisa Ishiguro
Rikako Sato
Toshihiko Mori
Hiroshi Tanaka
Mitsuo Narita
Takashi Nagano
Masato Owaku
Kensuke Miyajima
Atsushi Manabe
Point-of-care molecular diagnosis of Mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction.
description <h4>Objectives</h4>Macrolides are generally considered to be the drugs of choice for treatment of patients with Mycoplasma pneumoniae infection. However, macrolide-resistant M. pneumoniae has been emerging since about 2000. The Smart Gene® system (MIZUHO MEDY Co., Ltd., Tosu, Japan) is a novel fully automated system for detection of pathogens using the method of quantitative polymerase chain reaction (qPCR) with QProbe (QProbe PCR). The entire procedure is completed within 50 min and the size of the instrument is small (15 x 34 x 30 cm). The purpose of this study was to evaluate the usefulness of the Smart Gene® system for detection of M. pneumoniae and detection of a point mutation at domain V of the 23S rRNA gene of M. pneumoniae.<h4>Materials</h4>Pharyngeal swab samples were collected from 154 patients who were suspected of having respiratory tract infections associated with M. pneumoniae.<h4>Results</h4>Compared with the results of qPCR, the sensitivity and specificity of the Smart Gene® system were 98.7% (78/79) and 100.0% (75/75), respectively. A point mutation at domain V of the 23S rRNA gene was detected from 7 (9.0%) of 78 M. pneumoniae-positive samples by the Smart Gene® system and these results were confirmed by direct sequencing. The minimum inhibitory concentrations of clarithromycin among the 5 isolates of M. pneumoniae with a point mutation at domain V of the 23S rRNA gene were >64 μg/ml and those among the 33 isolates without a mutation in the 23S rRNA gene were <0.0625 μg/ml.<h4>Conclusion</h4>The Smart Gene® system is a rapid and accurate assay for detection of the existence of M. pneumoniae and a point mutation at domain V of the 23S rRNA gene of M. pneumoniae at the same time. The Smart Gene® system is suitable for point-of-care testing in both hospital and outpatient settings.
format article
author Nobuhisa Ishiguro
Rikako Sato
Toshihiko Mori
Hiroshi Tanaka
Mitsuo Narita
Takashi Nagano
Masato Owaku
Kensuke Miyajima
Atsushi Manabe
author_facet Nobuhisa Ishiguro
Rikako Sato
Toshihiko Mori
Hiroshi Tanaka
Mitsuo Narita
Takashi Nagano
Masato Owaku
Kensuke Miyajima
Atsushi Manabe
author_sort Nobuhisa Ishiguro
title Point-of-care molecular diagnosis of Mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction.
title_short Point-of-care molecular diagnosis of Mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction.
title_full Point-of-care molecular diagnosis of Mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction.
title_fullStr Point-of-care molecular diagnosis of Mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction.
title_full_unstemmed Point-of-care molecular diagnosis of Mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction.
title_sort point-of-care molecular diagnosis of mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/0d34ac3c3b04407ea84290c83899f472
work_keys_str_mv AT nobuhisaishiguro pointofcaremoleculardiagnosisofmycoplasmapneumoniaeincludingmacrolidesensitivityusingquenchingprobepolymerasechainreaction
AT rikakosato pointofcaremoleculardiagnosisofmycoplasmapneumoniaeincludingmacrolidesensitivityusingquenchingprobepolymerasechainreaction
AT toshihikomori pointofcaremoleculardiagnosisofmycoplasmapneumoniaeincludingmacrolidesensitivityusingquenchingprobepolymerasechainreaction
AT hiroshitanaka pointofcaremoleculardiagnosisofmycoplasmapneumoniaeincludingmacrolidesensitivityusingquenchingprobepolymerasechainreaction
AT mitsuonarita pointofcaremoleculardiagnosisofmycoplasmapneumoniaeincludingmacrolidesensitivityusingquenchingprobepolymerasechainreaction
AT takashinagano pointofcaremoleculardiagnosisofmycoplasmapneumoniaeincludingmacrolidesensitivityusingquenchingprobepolymerasechainreaction
AT masatoowaku pointofcaremoleculardiagnosisofmycoplasmapneumoniaeincludingmacrolidesensitivityusingquenchingprobepolymerasechainreaction
AT kensukemiyajima pointofcaremoleculardiagnosisofmycoplasmapneumoniaeincludingmacrolidesensitivityusingquenchingprobepolymerasechainreaction
AT atsushimanabe pointofcaremoleculardiagnosisofmycoplasmapneumoniaeincludingmacrolidesensitivityusingquenchingprobepolymerasechainreaction
_version_ 1718374389577154560